YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, Decreases Adrenal Androgen Synthesis by Inhibiting Cl7-20 Lyase Activity in NCI-H295 Human Adrenocortical Carcinoma Cells-Reference-Cited by-同舟云学术

YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, Decreases Adrenal Androgen Synthesis by Inhibiting Cl7-20 Lyase Activity in NCI-H295 Human Adrenocortical Carcinoma Cells

Published:1999 Issue:2 Volume:79 Page:213-220
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

Yukitaka Ideyama,Masafumi Kudoh,Kyoko Tanimoto,Yoko Susaki,Taiki Nanya,Takahito Nakahara,Hiroko Ishikawa,Takashi Fujikura,Hideyuki Akaza,Hisataka Shikama

Publisher

Elsevier BV

Subject

Pharmacology

Link

https://www.jstage.jst.go.jp/article/jjp/79/2/79_2_213/_pdf

Reference37 articles.

1. Molecular biology of steroid hormone synthesis;Miller;Endocr Rev,1988

2. 17α-Hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition;Yanase;Endocr Rev,1991

3. Inhibitors of cytochrome P45017α (17α-hydroxylase/C17,20 lyase);Barrie;Endocr-Relat Cancer,1996

4. Intracrinology: the basis for the rational design of endocrine therapy at all stages of prostate cancer;Labrie;Eur Urol,1993

5. Steroid synthesis inhibition by ketoconazole: sites of action;Trachtenberg;Clin Invest Med,1988

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The modulatory effects of ketoconazole on cytokine changes induced by selective surgical stress in male rats;Comparative Clinical Pathology;2022-06-11

2. Imidazole-based drugs and drug discovery: Present and future perspectives;Imidazole-Based Drug Discovery;2022

3. The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax;Toxicology;2019-09

4. A review of Cushing's disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism;Archives of Endocrinology and Metabolism;2018

5. Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies;Pituitary;2016-09-06